Loading stock data...

Hindustan Bio Sciences Limited

BSE: HINDBIO

BSE
8.34 0.01 (0.12%)

Prev Close

8.33

Open Price

8.33

Volume

6,507

Today Low / High

8.33 / 8.35

52 WK Low / High

5 / 10.32

Range

8 - 9

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 8.34, reflecting a change of 0.01 (0.12005%). The expected target range on the BSE is 8 - 9. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

23 Feb 8.33 0.00%
20 Feb 7.57 4.89%
19 Feb 7.30 3.70%
18 Feb 7.29 0.00%
17 Feb 7.67 0.00%
16 Feb 8.07 0.00%
13 Feb 8.49 0.00%
12 Feb 9.40 -5.00%
11 Feb 9.40 0.00%
10 Feb 8.54 4.92%
09 Feb 8.25 3.52%
06 Feb 8.19 -0.12%
05 Feb 7.46 4.56%
04 Feb 7.25 2.48%
03 Feb 7.51 -3.46%
02 Feb 7.44 0.00%
01 Feb 7.09 0.00%
30 Jan 6.76 0.00%
29 Jan 6.00 7.33%
28 Jan 6.12 0.33%

Hindustan Bio Sciences Limited Graph

Hindustan Bio Sciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Hindustan Bio Sciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 8.34, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 8.34 8.42 7.58 - 9.27
8.51 6.81 - 10.21
8.59 6.01 - 11.17
Bearish Scenario 8.34 8.26 7.43 - 9.08
8.17 6.54 - 9.81
8.09 5.66 - 10.52

Overview of Hindustan Bio Sciences Limited

ISIN

INE597C01021

Industry

Medical - Pharmaceuticals

Vol.Avg

9,887

Market Cap

85,389,164

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

18.15

DCF

-9

Financial Ratios Every Investor Needs

Stock Rating Details for HINDBIO

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.81 Cr 0.49 Cr 0.32 Cr 0.3927 0.00 Cr 0.06 Cr 0.10 Cr 0.10 Cr 0.10 0.10 Cr 0.1239
2024-03-31 1.04 Cr 0.64 Cr 0.31 Cr 0.3023 0.00 Cr 0.15 Cr 0.05 Cr 0.06 Cr 0.06 0.06 Cr 0.0554
2023-03-31 0.90 Cr 0.76 Cr 0.15 Cr 0.1630 0.00 Cr 0.03 Cr -0.05 Cr -0.04 Cr -0.04 -0.05 Cr -0.0448
2022-03-31 0.43 Cr 0.42 Cr 0.01 Cr 0.0227 0.00 Cr 0.03 Cr -0.45 Cr -0.52 Cr -0.50 -0.45 Cr -1.2019
2021-03-31 1.02 Cr 0.87 Cr 0.15 Cr 0.1437 0.00 Cr 0.04 Cr -0.15 Cr -0.94 Cr -0.92 -0.14 Cr -0.9200

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.01 Cr 3.42 Cr 2.52 Cr 0.9050 Cr 2.51 Cr 2.49 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr 2.39 Cr 0.0136 Cr
2024-03-31 0.04 Cr 3.37 Cr 2.57 Cr 0.8042 Cr 2.56 Cr 2.52 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0138 Cr
2023-03-31 0.01 Cr 3.29 Cr 2.54 Cr 0.7466 Cr 2.46 Cr 2.45 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr 2.30 Cr 1.4181 Cr
2022-03-31 0.01 Cr 2.98 Cr 2.19 Cr 0.7871 Cr 2.17 Cr 2.16 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.1170 Cr
2021-03-31 0.02 Cr 3.49 Cr 2.18 Cr 1.3046 Cr 1.86 Cr 1.84 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.4487 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.0271 Cr 0.0000 Cr -0.0512 Cr 0.0271 Cr -0.0241 Cr 0.0109 Cr 0.0000 Cr 0.0982 Cr -0.0512 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -1.4090 Cr 0.0000 Cr 1.4344 Cr -1.4090 Cr 0.0255 Cr 0.0350 Cr 0.0755 Cr 0.0533 Cr 0.1010 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -0.0498 Cr 0.0000 Cr 0.0502 Cr -0.0498 Cr 0.0004 Cr 0.0095 Cr 0.0000 Cr -0.0405 Cr 0.0502 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 -0.3117 Cr -0.0035 Cr 0.3076 Cr -0.3152 Cr -0.0076 Cr 0.0091 Cr -0.0035 Cr -0.5145 Cr 0.3387 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 0.5581 Cr 0.0000 Cr -0.7381 Cr 0.5581 Cr -0.1800 Cr 0.0167 Cr 0.0000 Cr -0.9553 Cr -0.7381 Cr 0.0000 Cr 0.3401 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 0.38 Cr 0.30 Cr 0.08 Cr 0.2191 0.06 Cr 0.08 Cr 0.08 0.08 Cr 0.2144
2025-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.07 Cr -0.06 Cr -0.06 -0.05 Cr 0.0000
2025-06-30 0.32 Cr 0.21 Cr 0.11 Cr 0.3417 0.00 Cr 0.01 Cr 0.01 0.01 Cr 0.0435
2025-03-31 0.39 Cr 0.24 Cr 0.15 Cr 0.3948 0.11 Cr 0.11 Cr 0.11 0.11 Cr 0.2826
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.04 Cr -0.04 Cr -0.04 -0.04 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.02 Cr 0.00 Cr 0.02 Cr 0.05 Cr 0.00 Cr 0.65 Cr 0.44 Cr 3.50 Cr 2.64 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.90 Cr
2025-03-31 0.01 Cr 0.00 Cr 0.01 Cr 0.44 Cr 0.00 Cr 1.00 Cr 0.03 Cr 3.42 Cr 2.52 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.18 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.84 Cr
2024-09-30 0.18 Cr 0.00 Cr 0.18 Cr 0.05 Cr 0.00 Cr 0.75 Cr 0.03 Cr 3.17 Cr 2.33 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹835.05 ₹100,208,823,304.00 ₹147,497.00

Key Executives

Chief Financial Officer & Director
Jaison George

Gender: male

Year Born: 1965

Chairman & Managing Director
Jampana Venkata Rama Mohan Raju

Gender: male

Year Born: 1958

Company Secretary & Compliance Officer
Shailendra Vyas

Gender: male

Year Born:

FAQs about Hindustan Bio Sciences Limited

Who is the CEO of the company?

The CEO is Jampana Venkata Rama Mohan Raju.

What is the current market price of the stock?

The current price is ₹8.33.

What is the 52-week price range?

The range is ₹5-10.32.

What is the market capitalization of the company?

The market capitalization is ₹8.54 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 57.66.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Hindustan Bio Sciences Limited (ISIN: INE597C01021) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹8.54 crores and an average daily volume of 9,887 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.